Imricor Medical Systems, Inc., a medical device company, designs, manufactures, and sells magnetic resonance imaging (MRI) compatible products for the treatment of arrhythmias in Europe and North America. The company's principal products include the Advantage-MR EP Recorder/Stimulator System, an electrophysiology amplifier and recording system with integrated cardiac stimulator; Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode, an ablation dispersive electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. The company also performs contract research, as well as licenses its intellectual property for use in other MRI-compatible devices. In addition, the company's products in commercialization pipeline includes diagnostic catheters, and steerable sheath and transeptal needles. It primarily operates in the cardiac catheter ablation market. Imricor Medical Systems, Inc. has strategic relationships with Siemens Healthcare GmbH and Koninklijke Philips N.V. The company was founded in 2006 and is headquartered in Burnsville, Minnesota.
Industry, Sector and Symbol
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone952-818-8400
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$370,552.00
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB (ASX:IMR) Frequently Asked Questions
What is Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB's stock symbol?
Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB trades on the ASX under the ticker symbol "IMR."
Has Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB been receiving favorable news coverage?
News articles about IMR stock have been trending somewhat negative on Wednesday, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB earned a coverage optimism score of -1.4 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB.
Who are some of Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB's key competitors?
Some companies that are related to Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB include Zynex (ZYXI), Draegerwerk AG & Co KGaA (DRW3), Creo Medical Group (CREO), Medica Group (MGP), Hamilton Thorne (HTL), Electromed (ELMD), Electromed (ELMD), Cyclopharm (CYC), Advanced Oncotherapy (AVO), MRI Interventions (MRIC), Kromek Group (KMK), Patient Home Monitoring (PTQ), REVA Medical (RVA), Protech Home Medical (PHM) and Impedimed (IPD).
What other stocks do shareholders of Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB own?
Who are Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB's key executives?
Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB's management team includes the folowing people:
- Mr. Steve Wedan, CEO, Pres & Chairman of Board (Age 52)
- Ms. Lori Milbrandt, CFO & VP of Fin.
- Mr. Gregg Stenzel, VP of Operations
- Mr. Greg Englehardt, Director of Sales
What is Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB's stock price today?
One share of IMR stock can currently be purchased for approximately A$1.68.
How big of a company is Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB?
What is Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB's official website?
How can I contact Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB?
The company can be reached via phone at 952-818-8400.
MarketBeat Community Rating for Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB (ASX IMR)
MarketBeat's community ratings are surveys of what our community members think about Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB and other stocks. Vote "Outperform" if you believe IMR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IMR will underperform the S&P 500 over the long term. You may vote once every thirty days.
